Ra Capital Management, Director: Dice Therapeutics DICE Buy · Filed 23/03/27

Trade details

Type: Insider buy
Amount: $4,136,223.63
Shares · price: 155,089 sh · $26.67 a share
Held after: 6,217,593 sh
Stock: Dice Therapeutics DICE
Person: Ra Capital ManagementDirector
Trade date: 23/03/23
Filed: 23/03/27
Days to filing: 4 days

5 insiders bought this week

Insiders buying this week: 5 insiders
Holding change: +2.6%

Dice Therapeutics trades, last 26 weeks

What else happened in Dice Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/21~23/04/22

Ra Capital Management's recent trades

Ra Capital ManagementDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
Ra Capital ManagementDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
Ra Capital Management10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17
Ra Capital Management10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$9,693
27,695 sh
$9,693
Filed 06/22
Traded 06/17
Ra Capital Management10% Owner
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.5M
61,523 sh
$1.5M
Filed 06/17
Traded 06/16